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Abstract 
An overview of Men’s Health Clinics offering Testosterone Therapy in a Midwest State. 
Introduction/ Background – Since 2001, there has been a 300% increase in the use of Testosterone 
therapy. However, there remains limited published data on the demographics of facilities and providers 
that advertise this service. This study aims to look at such demographics of advertised Men’s health 
clinics in Nebraska. 
Methods/ Materials – An internet search was conducted with the phrases “Nebraska Male health clinics, 
Nebraska Low T/testosterone, Nebraska Hormone Replacement Therapy”. All clinics that were found 
offering Testosterone therapy with Men’s health in their mission statement were included. Data was 
gathered using 6 questions, with answers obtained from the public website or by calling the office. 
Results – 19 different facilities were found that self-identified as Men’s Health clinics. 5/19 facilities were 
nationally corporate owned, 13/19 were individually owned, and 1 was an academic university. All offered 
Testosterone Therapy. Of the 19 facilities, 10/19 branded themselves primarily as Men’s Health Clinics. 6/
10 out of those offered testosterone therapy, Plasma infusion, and Penile Shockwave Therapy. Those that 
offered services other than Men’s health were marketed as Medical Spas and Aesthetic centers, offering 
hormone replacement therapy, aesthetics, and anti-aging treatments. 10/19 Clinics had no MD listed and 
visits would be with a mid-level provider (NP or PA). Only 1/19 provided prices online, others required 
consultation before prices would be given. Of the 19 facilities, only 6 accept insurance and the rest are 
cash-pay clinics only. 
Conclusions – Of the Nebraska clinics that self-identify as men’s health clinics, many are individually 
owned clinics with a focus on hormone replacement or aesthetics. Of those clinics, many were run 
entirely by mid-levels or with a supervising MD overseeing mid-levels. Less than 1/3rd of facilities accept 
insurance and there is a lack of price transparency. 
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Abstract
Introduction: Since 2001, there has been 
a 300% increase in the use of testosterone 
therapy. However, there remains limited 
published data on the organizational structure 
of the facilities and demographics of the 
providers that offer this service. This study 
aims to look at the structure and provider 
demographics of advertised men’s health 
clinics in Nebraska.
Methods: An internet search was conducted 
with the phrases “Nebraska male health 
clinics, Nebraska low T/testosterone, 
Nebraska hormone replacement therapy.” All 
clinics that were found offering testosterone 
therapy with men’s health in their mission 
statement were included. Data were gathered 
using six questions, with answers obtained 
from the public website or by calling the 
office. 
Results: Nineteen different facilities were 
found that self-identified as men’s health 
clinics. Five out of the nineteen facilities were 
owned by national corporate entities, 13/19 
were individually owned, and one was located 
at an academic university. All facilities offered 
testosterone therapy. Of the 19 facilities, 
10/19 branded themselves primarily as men’s 
health clinics of which six offered testosterone 
therapy, plasma infusion, and penile 
shockwave therapy. Ten out of the 19 clinics 
had no MD listed and visits were with an 
advanced practice provider (NP or PA). Only 
1/19 provided prices online; whereas, others 
required consultation before prices would be 
given. Of the 19 facilities, only six accepted 
insurance.
Conclusions: Of the Nebraska clinics that 
self-identify as men’s health clinics, many are 
individually owned clinics. Of those clinics, 
over half were run entirely by advanced 
practice providers or with a supervising MD 
overseeing them. Less than one-third of 
facilities accept insurance and there is a lack 
of price transparency.
Introduction
Hypogonadism is a clinical condition defined 
as low levels of serum testosterone associated 
with specific signs and symptoms.1 When 
hypogonadism occurs in an older male, the 
condition is termed late onset hypogonadism 
(LOH). Common symptoms include decreased 
muscle mass and strength, increase in central 
body fat, loss of libido, memory loss, and 
difficulty in concentration. However, these 
symptoms can be hard to differentiate from 
regular aging associated symptoms. The 
American Urological Association guideline 
states that clinical hypogonadism is defined as 
serum testosterone levels lower than 300ng/
dl and treatment is clinically appropriate for 
any levels below this threshold.2 Treatment 
is in the form of prescription testosterone 
therapy (TTh), where extraneous testosterone 
hormone is introduced to the body to raise 
serum testosterone to a recommended 
level.3 Current methods include intradermal 
injections, transdermal patches, sub dermal 
pellets, or nasal application.
Prescription TTh remains a prevalent topic 
of discussion throughout the world. In the 
United States, the general public is exposed 
to an array of radio, television and internet 
advertisements, which is likely the major 
factor contributing to the 300% increase 
in testosterone use in men from 2002 to 
2013.4 Studies have shown that this increase 
in prescribing has been accompanied by 
increases in testosterone level testing, 
prescriptions of testosterone without the 
full diagnostic evaluation recommended 
by clinical practice guidelines and use 
of testosterone for unproven conditions.5 
Hundreds of men’s health clinics have 
opened to accompany this trend, marketing 
themselves in several ways to appeal to 
consumers.6 Alongside TTh, many of these 
clinics offer experimental non-FDA approved 
therapies such as penile shockwave therapy 
and plasma infusion, with claims they boost 
sexual libido and overall well-being. These 
experimental therapies have not been studied 
rigorously and there is no scientific literature 
proving their efficacy.7
Patients increasingly rely on the internet to 
answer their health-related questions.8 In 
addition, small studies reveal that people 
generally consider attributes such as 
professional design, ease of use and scientific 
touch when assessing the credibility of 
medical information online, and disregard 
disclaimers and disclosure statements.9 The 
increase in use of the internet by the public, 
along with the potentially poor ability to 
distinguish between credible and misleading 
information underscores the need for more 
rigorous research surrounding how online 
marketing may impact the patient’s view on 
health-related matters.
We conducted an exploratory study to 
determine what information is available online 
for patients seeking treatment at a men’s 
health clinic in Nebraska. To our knowledge, 
no previous studies have been performed that 
evaluate the structure of men’s health clinics, 
or demographics of providers working in 
these clinics. We also sought to determine the 
types of providers and therapies offered in 
these clinics.
Methods
We identified men’s health clinics in the 
State of Nebraska using Google incognito 
internet search with the phrases “Nebraska 
male health clinics, Nebraska Low T/
testosterone, Nebraska Hormone Replacement 
Therapy.” All clinics that were found offering 
testosterone therapy were reviewed. Data 
were gathered using six predetermined 
domains, with answers obtained from the 
public website or by calling the clinic directly 
for any information not available online. 
Transparency was measured by whether the 
information was publicly available online 
or over the phone. Clinics with multiple 
locations were treated as a single clinic for the 
analysis.
Results
Nineteen different facilities were found that 
self-identified as men’s health clinics. Of 
these 5/19 facilities were owned by national 
corporate entities, 13/19 were individually 
owned, and 1 was located at an academic 
university (our own institution) (Figure 1). 
On their websites, 19/19 listed services 
provided, 17/19 listed providers, and 1/19 
listed prices for treatment. All of the identified 
men’s health clinics offered Testosterone 
Replacement Therapy. Of the 19 facilities, 
10/19 branded themselves primarily as 
men’s health clinics of which six offered 
testosterone therapy, plasma infusion for 
erectile dysfunction, and penile shockwave 
therapy (Figure 2). Those that offered services 
other than Men’s health were marketed as 
medical spas and aesthetic centers, offering 
hormone replacement therapy, aesthetics, and 
anti-aging treatments. Regarding provider 
workforce, 10/19 clinics had no physician 
listed and visits were with an advance practice 
provider (NP or PA) (Figure 3). Seventeen of 
the 19 clinics listed provider qualifications 
on the website and the other two clinics were 
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transparent of provider qualifications over the 
phone. Only 1/19 provided prices online while 
the others required consultation before prices 
would be given. Information about insurance 
was posted online for 13/19 clinics. Of the 19 
facilities, only six accepted insurance and the 
rest are cash-pay clinics only. 
Discussion
Since, the early 2000’s, there has been a 
dramatic increase in testosterone prescription 
for TTh. In the decade from 2001 through 
2011, testosterone prescriptions tripled from 
0.81% to 2.91% of all men over 40, of which 
many did not have a clear clinical reason.1,6 
Studies have shown that the major reasons 
for the increase is due to Direct to consumer 
advertising and non-FDA approved Late 
Onset Hypogonadism (LOH), which lacks 
clinical evidence.10 
Of the facilities offering testosterone therapy 
in Nebraska, we found the majority were 
clinics branded as Men’s testosterone clinics 
or Men’s health clinics with a primary focus 
on hormone replacement therapy and the 
rest as aesthetic centers or medical spas. Of 
these facilities, 13/19 were individual private 
clinics with only 1 academic center found 
to offer TTh. Many of the facilities were 
staffed primarily with advanced practice 
providers such as NPs or PAs with or without 
a supervising physician. All were very 
transparent about provider qualifications. 
We also found that there exists a lack of price 
transparency for services offered by most 
clinics. Only 1/19 of the facilities had prices 
listed on their website. The other clinics had 
no prices listed on their website and declined 
to provide price of treatment over the phone. 
Other reviews of Male clinics have found that 
costs for TTh can be up to $400 monthly.12 In 
addition, two-thirds of the facilities are cash-
pay only, with no price transparency until 
after the initial exam and testing. In a study 
of primary care clinics, 60% provided cost 
estimates of the initial visit, showing that it is 
possible to provide this to interested patients.13 
The out of pocket financial costs of TTh can 
be significant, but there exists a lack of data 
on safety and efficacy of male health clinics. 
The main concern with centers that monetize 
TTh is whether they are listening to the 
entirety of the patient’s symptoms, discussing 
lifestyle modifications, and properly treating 
the patient’s condition. Previous studies of 
TTh clinic websites have shown that they 
promote the benefits of TTh while neglecting 
to mention the risks.14 




























Figure 1. Ownership demographics of men’s health clinics in Nebraska.
Figure 2. Treatments offered by men’s health clinics in Nebraska.
Figure 3. Degree of the medical provider at the men’s health clinic.
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The American Urological Association 
currently defines hypogonadism as 
testosterone <300 ng/dl. They recommend 
treating hypogonadism until serum 
testosterone is in the range of 450-600 ng/dl, 
but many clinics advertise recommend raising 
testosterone levels to much higher levels.15 In 
2014, The FDA added a black box warning of 
cardiovascular risks with TTh and rebranded 
the indication to pathological hypogonadism 
in an effort to prevent unnecessary 
prescribing, which led to a decrease in 
testosterone prescription from 2013 – 2016. 
Unfortunately, it appears that many clinics 
are still using the FDA off-label Late Onset 
Hypogonadism (LOH) as justification for 
TTh.16 Many of the male health clinics are 
also advertising on their websites non-
FDA approved plasma infusion and penile 
shockwave therapy, which has no clinical 
evidence to demonstrate its efficacy. The 
Sexual Medicine Society of North America 
considers these experimental therapies and 
should be restricted to clinical trial research.17 
These three therapies are advertised on 
websites as treatments to increase libido 
and energy, but all these therapies lack both 
FDA-approval and stricter regulations. This is 
troublesome since consumers are increasing 
relying on the internet for their first source 
of health information, before physician 
consultation.8 Therefore, they might be 
inclined to believe that the treatments offered 
are standard of care and be misled regarding 
safety and efficacy. 
 There are several limitations to our study. Our 
study relied on internet search results, and as 
the internet is constantly changing, we may 
have missed some clinics that do not have a 
website or do not promote themselves visibly 
online. Also, it is possible that some websites 
may be outdated and do not accurately 
represent the provider or services offered at 
this time. Additionally, we confined our focus 
to our state to understand this microcosm 
which may not be generalizable to larger 
population centers across the U.S. 
Conclusion
Men with hypogonadal symptoms or erectile 
dysfunction continue to seek treatment 
wherever they can. Many clinics across the 
country now serve these needs directly by 
marketing themselves as men’s health clinics. 
In our local review of publicly available 
information, these men’s clinics are mostly 
privately owned and offer cash-based services 
with minimal price transparency. Many offer 
therapies that either have minimal supporting 
evidence or are not FDA approved. While 
many men may benefit from these therapies, 
they must be educated and also understand 
any risks that accompany these non-FDA 
approved treatments offered by providers 
without a comprehensive review of their 
entire health profile. 
https://doi.org/10.32873/unmc.dc.gmerj.2.2.004
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